PRECISION BIOSCIENCES INC — Director's Dealing 2021

Apr 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-04-12

Reporting Person: KANE MATTHEW R. (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-12	Common Stock	M	21514	$0.04	Acquired	1974537	Direct
2021-04-12	Common Stock	S	9741	$8.67	Disposed	1964796	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-12	Employee Stock Option (Right to Buy)	$0.04	M	21514	Disposed	2021-05-17	Common Stock (21514)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10841	Indirect

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

F2: Shares are held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

F3: The option is fully vested and exercisable.